More Press Releases

View Older Stories View Newer Stories

Oct 18, 2025 10:30AM ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
Oct 18, 2025 10:30AM ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Tri
Oct 18, 2025 10:30AM PADCEV™ Plus KEYTRUDA™, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
Oct 18, 2025 10:30AM ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTI
Oct 18, 2025 10:00AM BexBack Launches No KYC, 100x Leverage, and $50 Welcome Bonus for Easy Crypto Futures Trading!
Oct 18, 2025 10:00AM Nasdaq Halts Platinum Analytics Cayman Limited
Oct 18, 2025 10:00AM Nasdaq Halts Etoiles Capital Group Co., Ltd.
Oct 18, 2025 10:00AM Nasdaq Halts Pitanium Limited
Oct 18, 2025 09:45AM Vakiav Launches their First Window Smart Bird Feeder Designed for Effortless Setup and Instant Connection
Oct 18, 2025 09:43AM Astra Bitcoin: Dr. Antoun Toubia Launches a Revolutionary Asset-Backed Ecosystem Built on Ethereum
Oct 18, 2025 10:36AM Can Level 3 Interchange Rates Transform Your Margins Overnight?
Oct 18, 2025 12:31PM Starting Small Checklist for Bulk Custom Phone Covers
Oct 18, 2025 09:20AM China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks
Oct 18, 2025 09:13AM Global Sources Hong Kong Shows Phase II Officially Opens: AI Pavilion Debuts, Spotlighting Latest AI and Robotics Trends
Oct 18, 2025 09:05AM Infrrd Announces the Official Launch of Ally: The First Agentic AI Workforce for Mortgage Auditing
Oct 18, 2025 09:00AM Epomaker Unveils Magcore65 Lite: A Compact, Stable, and Durable Inductive Keyboard
Oct 18, 2025 08:50AM Growing Up Spooky - Families Raised in America's Most Legendary Haunted Attractions
Oct 18, 2025 11:02AM Looking for the Best Tax Advisors in Bangalore? Here’s Why Pyng Is the Right Choice
Oct 18, 2025 08:00AM MorseLife Named a Fortune Media 2025 Best Workplace in Aging Services
Oct 18, 2025 08:00AM DeFi crypto Mutuum Finance (MUTM) Onboards Over 17,300 Investors With 70% of Phase 6 Allocated
Oct 18, 2025 08:00AM NuCana Presents Encouraging Data on NUC-7738 in Combination with PD-1 Inhibitors using Primary Patient-Derived Organoids and Autologous Tumor-Infiltrating Lymphocytes at the ESMO Congress 2025
Oct 18, 2025 08:00AM University of Phoenix College of Social and Behavioral Sciences Leadership Publishes White Paper on Trauma-Informed Education
Oct 18, 2025 07:56AM Reconstruction and Opportunities: The CDFG Consumer White Paper 2024-2025 is Released
Oct 18, 2025 07:00AM Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical O
Oct 18, 2025 07:23AM Andrew Left's Trial Begins -- Could Barry Honig Finally See Vindication?
Oct 18, 2025 07:22AM Stop Believing Fake News: The Truth About MEXQuick and Scam Rumors
Oct 18, 2025 06:17AM SurviveX Launches Tea-Tree-Infused Hydrogel Burn Dressings — Instant Cooling Relief with Professional-Grade Care
Oct 18, 2025 06:15AM Masters Of Ring Entertainment Revolutionizes Professional Wrestling Industry with Triple Platform Launch
Oct 18, 2025 07:13AM IDCXS Crypto Exchange Cuts Latency to Sub-Millisecond
Oct 18, 2025 06:05AM Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platform’s Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Oct 18, 2025 06:00AM KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Ba
Oct 18, 2025 06:00AM Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Oct 18, 2025 06:00AM Newfoundland and Labrador Victims and Survivors of Alcohol and Drug-Related Crashes Remembered at MADD Canada’s Annual Memorial Monument Ceremony
Oct 18, 2025 06:00AM Nuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025
Oct 18, 2025 05:40AM Discover Our New Car Detailing Package
Oct 18, 2025 06:25AM InvidiaTrade y TradingView se unen para ofrecer a los traders latinoamericanos una experiencia de analisis y ejecucion sin limites
Oct 18, 2025 05:15AM ITM Announces Phase 3 COMPETE Data Demonstrating a Statistically Significant Higher Objective Response Rate with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus in Patients with Gastroenteropancreati
Oct 18, 2025 06:02AM Oklahoma Plastic Surgeons Cements Reputation Among Best Tummy Tuck Surgeons in Oklahoma City Releasing Abdominalplasty Resource Library
Oct 17, 2025 06:08PM /U P D A T E -- GRAIL, Inc./
Oct 18, 2025 05:00AM Parental Control App for iPhone (2025): Qustodio Named Leading iPhone Safety App by Expert Consumers
Oct 18, 2025 04:30AM Celcuity Presents Updated Data at the 2025 ESMO Congress from Phase 1 Study Evaluating Gedatolisib Plus Darolutamide in Men with Metastatic Castration Resistant Prostate Cancer (“mCRPC”)
Oct 18, 2025 04:30AM Celcuity Provides Update on Status of the PIK3CA Mutated Cohort of Phase 3 VIKTORIA-1 Trial and Releases Additional Data Analysis From Phase 1b Clinical Trial
Oct 18, 2025 04:30AM Detailed Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial Presented at 2025 ESMO Congress Demonstrate Potential for Gedatolisib Regimens to be Practice Changing for Patients with HR+/
Oct 18, 2025 04:20AM New Partnership Enhances Contractor Exit Strategies
Oct 18, 2025 04:10AM Rocky Hill Equipment Rentals Expands with New Location in Pflugerville, TX
Oct 18, 2025 05:07AM Wendy Joy Inspires with Insights and Experiences
Oct 18, 2025 07:02AM How to Build Real Instagram Followers on Instagram?
Oct 18, 2025 03:23AM Kura Oncology Announces Preliminary Data from Its Farnesyl Transferase Inhibitor (FTI) Programs at the 2025 European Society for Medical Oncology (ESMO) Congress
Oct 18, 2025 03:00AM The secrets to packing fragile items from Paso Robles self-storage
Oct 18, 2025 03:00AM Central Pacific Construction announces Paso Robles pool contracting services
View Newer Stories View Older Stories